Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01808053|
Recruitment Status : Completed
First Posted : March 8, 2013
Last Update Posted : January 7, 2014
|Condition or disease||Intervention/treatment|
|Congestive Heart Failure||Device: BodyGuardian remote health monitoring system|
|Study Type :||Observational|
|Actual Enrollment :||20 participants|
|Official Title:||Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects|
|Study Start Date :||March 2013|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||December 2013|
Healthy older and independently living adults
The BodyGuardian remote health monitoring system will used by healthy older and independently living adults
Device: BodyGuardian remote health monitoring system
The remote health management system connects personal health sensors with secure mobile communication devices. It is also able to give immediate feedback to the user. The solution is a multi-tiered mobile health platform. The front-end includes an adhesive snap-strip body sensor (BodyGuardian) that can measure HR, ECG, respiration rate (RR), and activity which is FDA approved for detection of non-lethal cardiac arrhythmias. It can wirelessly communicate with off-body sensors such as a BP cuff and scale to incorporate BP and weight data based on automated algorithms and can solicit symptoms from the user. It can also be used as an event recorder inputting symptoms and recording simultaneous physiologic data.
- Number of subjects with successful data transfer at the end of 30 day monitoring period. [ Time Frame: approximately at the end of 30 day monitoring period ]Data collected will be reviewed by engineering collaborators.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01808053
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Charles J Bruce, MBChB||Mayo Clinic|